Standardized Eucommia Extract in the Treatment of Hypertension



Status:Completed
Conditions:High Blood Pressure (Hypertension)
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - 70
Updated:4/21/2016
Start Date:May 2007
End Date:January 2013

Use our guide to learn which trials are right for you!

Evaluation of the Safety and Efficacy of a Standardized Eucommia Extract in the Treatment of Hypertension

The purpose of this study is to demonstrate that eucommia, an herb used in China for making
tea, is safe and effective for lowering blood pressure in humans with high blood pressure.

Eucommia is an herb used as a tea in China and by traditional Chinese doctors to treat high
blood pressure. People with high blood pressure in Russia were given eucommia with a
reduction in blood pressure and without side effects. LSU Board of Regents supported this
research to develop an herbal product that will maintain a healthy blood pressure. Dr. Liu
with the LSU Ag Center extracted and standardized the eucommia. Dr. Baker with the LSU Vet
School conducted safety studies in rats finding that eucommia was without side effects at 7
times the doses to be used in this study and there was a reduction in blood pressure in the
rats. Dr. Greenway demonstrated that eucommia extract is a beta-adrenergic blocker, a
mechanism used in approved blood pressure medications like propanolol.

Thirty healthy subjects will participate in this study who are between 18 and 70 years of
age with less than 2 cardiovascular risk factors, and an average blood pressure of
120-160/80-100 on 3 screening visits to the Pennington Center clinic each a week apart. This
level of high blood pressure can be safely treated with diet and lifestyle change alone for
a 6 to 12-month period.

During screening subjects will come to the Pennington Center clinic on 3 occasions and have
a medical history, physical examination, blood tests, and electrocardiogram (heart tracing)
on 1 of these 3 visits, and 24-hour blood pressure monitoring. Visits will last
approximately 30 minutes to 1 hour. If the subject is of childbearing potential, a pregnancy
test will be done. A small box will be given to subjects that will be attached to a blood
pressure cuff to carry on an arm for 24 hours on one occasion. This device will
automatically take blood pressure every half hour during the 24-hour period.

Qualifying subjects return to the Pennington Center clinic on 3 occasions and will be asked
to take 2 capsules 3 times a day for 2 weeks. The capsules could contain 1 gram of eucommia
extract or a placebo (inactive sugar pill). Subjects have a 50:50 chance of receiving the
eucommia and the assignment to eucommia or placebo will be made by chance (like flipping a
coin). On each visit subjects will return the pill bottle, be given new medication to last
until the next visit, be asked about any side effects, and have blood pressure taken. They
will also be questioned about any adverse events. If blood pressure exceeds 180/110 on these
visits, the subjects will be withdrawn from the trial and referred to their physician. At
the end of the study, the blood tests, electrocardiogram, 24-hour blood pressure monitor,
and physical examination will be repeated. These visits will last approximately 30 minutes
to 1 hour, with the exception of visit 4 which will last approximately 1½ hours. The entire
study will last approximately 5 weeks.

The effectiveness of eucommia in reducing blood pressure will be assessed by comparing the
blood pressure readings from clinic visits and the 24-hour blood pressure monitoring. The
safety of eucommia will be assessed from the blood tests, side effects, urinalysis,
electrocardiogram, and physical examination. Subjects will be paid $35 per non-screening
visit and an extra $30 for completing the study for a total of $100. At the end of the study
or at the time of early termination, subjects will be instructed in the diet and lifestyle
changes recommended by the National Institutes of Health and referred to their physicians.

There have been no side effects reported from taking eucommia and there was no toxicity in
rats given the equivalent of 7 times the dose to be used in this trial. Drawing blood from
an arm vein can cause discomfort from the needle, bruising, and rarely fainting or
infection. These risks will be minimized by trained technicians and sterile technique. The
24-hour blood pressure monitor may be annoying and interrupt sleep when it automatically
takes blood pressure.

Eligible criteria:

- Are a healthy male or female

- Are 18 to 70 years of age

- Have a BMI (a number calculated from your height and weight) less than 40

- Have an average blood pressure measure between 120-160/80-100

Ineligible criteria:

- Smoke or have smoked in the past 6 months

- Have diabetes mellitus

- Have heart disease including left ventricular hypertrophy, prior myocardial
infarction (heart attack), angina pectoris (heart pain), a prior revascularization
procedure (heart bypass), heart failure or stroke

- Have nephropathy (kidney disease)

- Have peripheral arterial disease (blockage of the arteries to your body)

- Have retinopathy (disease of the back of the eye)

- Take a beta-adrenergic blocking drug

- Regularly use medications that would influence weight, or unstable doses of medicines
that would affect blood pressure

- Are pregnant or nursing a baby

- Are taking blood pressure medications and not on a stable dose for 3 months
We found this trial at
1
site
6400 Perkins Rd
Baton Rouge, Louisiana 70808
(225) 763-2500
Pennington Biomedical Research Center Unlike other medical research facilities where science occurs in separate labs...
?
mi
from
Baton Rouge, LA
Click here to add this to my saved trials